ASGE Guidelines

ASGE evidence-based guidelines provide clinicians with recommendations for the evaluation, diagnosis, and management of patients undergoing endoscopic procedures of the digestive tract. Guidelines are not a substitute for physicians’ opinion on individual patients. Final decision on an intervention should always be based on local expertise and patient preferences.

All recommendations follow a rigorous process based on a systematic review of medical literature as outlined by the National Academy of Medicine (formerly Institute of Medicine) standards for guideline development.

Whenever possible, guidelines are based on the GRADE (Grading of Recommendation Assessment, Development and Evaluation) methodology.

Panels consist of content experts, stakeholders from other specialties, patient representatives, and members of the ASGE Standards of Practice (SOP) Committee.

Each recommendation is based on consideration of the best medical literature, the balance between risks and benefits, cost-effectiveness, patients’ values, and equity.

Panel members provide ongoing conflict of interest (COI) disclosures, including intellectual conflicts of interest, throughout the development and publication of all guidelines in accordance with the ASGE Policy for Managing Declared Conflicts of Interests.

ASGE strives to provide clinically relevant and practical recommendations, which can help standardize patient care and improve outcomes.

If you have any questions or suggestions, please contact Customer Support at Info@asge.org.

The following information is intended only to provide general information and not as a definitive basis for diagnosis or treatment in any particular case. It is very important that you consult your doctor about your specific condition.

Newly Published
GRADE Guidelines
Upper GI
Lower GI

The role of endoscopy in the patient with lower GI bleeding

Nov 14, 2016, 20:26 PM
Lower GI bleeding (LGIB) is diagnosed in 20% to 30% of all patients presenting with major GI bleeding.4-6 The annual incidence of LGIB is 0.03%, and it increases 200- fold from the second to eighth decades of life.7-9 The mean age at presentation ranges from 63 to 77 years.9,10 Approximately 35.7 per 100,000 adults in the United States are hospitalized for LGIB annually, and a full-time gastroenterologist manages more than 10 cases per year.8,11,12 Although blood loss from LGIB can range from trivial to massive and life-threatening, the majority of patients have self-limited bleeding and an uncomplicated hospitalization. Compared with acute upper GI bleeding (UGIB), patients with LGIB tend to present with a higher hemoglobin level and are less likely to develop hypotensive shock or require blood transfusions.6,13 The mortality rate ranges from 2% to 4%8,10,14 and usually results from comorbidities and nosocomial infections.15 A recent epidemiologic study reported a decreased incidence of LGIB (41.8/100,000 in 2001 vs 35.7/100,000 in 2009; P Z .02) and a lower ageadjusted and sex-adjusted case fatality rate (1.93% in 2001 vs 1.47% in 2009; P Z .003) over the past decade.
Title : The role of endoscopy in the patient with lower GI bleeding
Doi org link : http://dx.doi.org/10.1016/j.gie.2013.10.039
Volume : Gastrointest Endosc 2014; Volume 79, Issue 6; P875-885
URL :
Select a choice : Keep
Content created : Aug 13, 2014, 03:17 AM
File size :
Number :
ExternalPK : 17475
Categories :
  • GI bleeding
  • Lower GI
  • Polypectomy
Tags :
Biliary and Pancreatic Endoscopy
Adverse Events
Privileging and Credentialing
GI Endoscopy Unit Operations
Screening and Surveillance in Premalignant Conditions
Procedural Management in Endoscopy
Miscellaneous
Guidelines in Spanish

In Progress Guidelines

ASGE Guideline on management of code status in the periendoscopic period

Estimated 2025

Quality in Endoscopy

Quality documents define the indicators of high-quality endoscopy and how to measure it. ASGE quality indicators are based on a rigorous review process which results in valid metrics for evaluating GI endoscopic procedures.

Quality in Endoscopy

Public Comment

ASGE guidelines approaching publication are available on the website for 30 days for public comment. All reviewers are required to submit a conflict-of-interest disclosure and acknowledge a non-disclosure agreement for the guideline draft. All comments will be reviewed by the SOP Committee. Revisions to the draft are at the discretion of the lead authors and the SOP Committee.

ASGE Guideline on endoscopic management of benign and malignant colonic strictures

Comment

Endoscopic treatment for the management of complications post bariatric surgery: European Society of Gastrointestinal Endoscopy and American Society of Gastrointestinal Endoscopy position statement

Comment